Gene mutations rated as (likely) pathogenic that were already identified in low-grade and moderate dysplastic samples included inactivating mutations in the tumor suppressor genes TP53, CDKN2A, and NOTCH1, implying a crucial role in stepwise carcinogenesis towards HNSCC. This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.